Acarix, a leader in acoustic and AI-based cardiac diagnostics, announced today, in collaboration with the American College of Cardiology (ACC), a first edition of a framework for the CADScor System.
News | Artificial Intelligence
Acarix and the American College of Cardiology Collaborate on First Edition Framework for CADScor System

May 9, 2023 — Acarix, a leader in acoustic and AI-based cardiac diagnostics, announced today, in collaboration with the ...

Home May 09, 2023
Home
Marshall-Plan study presented in a late breaking science session today at EHRA 2023
News | Atrial Fibrillation
Novel Ablation Strategy Improves Freedom from Arrhythmias in Atrial Fibrillation Patients

May 8, 2023 — An innovative three-step ablation approach including ethanol infusion of the vein of Marshall improves ...

Home May 08, 2023
Home
This recent advance fulfils the requirements needed to promote an efficient translation of innovations and new treatments from the bench to the bedside in this field
News | Stroke
New Reproducible and Minimally Invasive Stroke Model Through an Endovascular Approach

May 8, 2023 — Researchers of the Cellular and Molecular Neurobiology (CMN) Research Group at the Germans Trias i Pujol ...

Home May 08, 2023
Home
Ucardia, a cardiac conditioning software developer, announced today that it has reached an agreement to acquire Phas3
News | Remote Monitoring
Ucardia Announces Acquisition of PHAS3; Launches Cardiologist Practice Remote Patient Monitoring Offering

May 8, 2023 — Ucardia, a cardiac conditioning software developer, announced today that it has reached an agreement to ...

Home May 08, 2023
Home
72-year-old with intermediate (50-70%) stenosis in distal right coronary artery, who underwent coronary CTA due to atypical chest pain.
News | Computed Tomography (CT)
Rapid Onsite FFR-CT Algorithm Helps Facilitates Clinical Adoption

May 5, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR), a high ...

Home May 05, 2023
Home
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the wealth of technological advancements, bringing the necessary tools together in a streamlined workflow has remained a challenge for clinicians
Sponsored Content | Case Study | Baylor Scott and White Heart Hospital | Karim Al-Azizi, M.D.
Contemporary PCI: Utilizing State-of-the-Art Technology to Achieve the Best Outcomes

While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...

Home May 05, 2023
Home
A new book written by and for interventional cardiologists provides a collection of detailed case studies, clinical data and imagery, according to Cedars-Sinai, whose team from Smidt Heart Institute is among the editors of the publication.
Feature | Cardiovascular Education | Christine Book
Book Offering Collection of Complex Interventional Cardiology Cases Published by Team from Cedars-Sinai Smidt Heart Institute

May 4, 2023 — A new book on a broad collection of cases, led by a team of investigators from the Smidt Heart Institute ...

Home May 04, 2023
Home
Screen Shot 2023-05-03 at 11.31.20 AM
Feature | Cardiac Imaging | By Mohammad Sahebjalal, MD
Radiation Scatter 101: Risks, Dangers and Latest Solutions

Invented in 1896 by Enrico Salvioni, the fluoroscope remains a flagship technology of modern medicine. The live video X ...

Home May 04, 2023
Home
This study evaluates SELUTION SLR in the treatment of occlusive disease of the superficial femoral artery (SFA) and proximal popliteal artery (PPA) and has been designed to support FDA approval
News | Drug-Eluting Balloons
MedAlliance Enrolls First US Patient into its Third FDA IDE Study: SFA SELUTION4SFA

May 4, 2023 — The first US patient has been enrolled in the SELUTION4SFA Sirolimus DEB study by Dr. Arthur Lee at the ...

Home May 04, 2023
Home
Investigators are one step closer to achieving this breakthrough in preventive healthcare and offering patients personalized predictions of their heart health thanks to a novel deep-learning tool and artificial intelligence (AI) algorithm developed at Cedars-Sinai.
News | Artificial Intelligence
New AI Tool Developed at Cedars-Sinai Can Predict Adverse Cardiac Events Like Heart Attacks, and Show How Risk Changes Over Time

May 4, 2023 — What if you could predict if-or when-your patient might experience a heart attack, cardiac arrest or ...

Home May 04, 2023
Home
Transaction values Avertix at an enterprise value of $195 million
News | Implantable Cardiac Monitor (ICM)
Avertix, Maker of First and Only FDA-Approved Implantable Heart Attack Warning System, to Become Publicly Traded via Merger with BIOS Acquisition Corporation

May 4, 2023 — Avertix Medical, Inc., formerly known as Angel Medical Systems, Inc., a company focused on improving long ...

Home May 04, 2023
Home
A team led by researchers at The University of Texas at Austin has developed an ultrathin, lightweight electronic tattoo, or e-tattoo, that attaches to the chest for continuous, mobile heart monitoring outside of a clinical setting
News | Wearables
Chest e-Tattoo Boasts Major Improvements in Heart Monitoring

May 3, 2023 — A new flexible, wearable medical device could provide a major boost in the fight against heart disease ...

Home May 03, 2023
Home
The Society of Cardiovascular Computed Tomography (SCCT) Board of Directors is proud to announce that Martha Gulati, MD, FACC, FAHA, FASPC, FESC has been named the recipient of the 2023 Arthur S. Agatston Cardiovascular Disease Prevention Award
News | Cardiovascular Business
SCCT Honors Dr. Martha Gulati with 2023 Arthur S. Agatston Award

May 3, 2023 — The Society of Cardiovascular Computed Tomography (SCCT) Board of Directors is proud to announce that ...

Home May 03, 2023
Home
Leading physicians from Cleveland Clinic to present data from three posters that showcase the Company’s novel PURE EP Platform
News | EP Device Monitoring Systems
BioSig to Highlight New Data from the PURE EP Platform at Heart Rhythm 2023

May 3, 2023 — BioSig Technologies, Inc., a medical technology company delivering unprecedented accuracy and precision to ...

Home May 03, 2023
Home
MOJAVE study on track to start in Q2 2023 as planned, with initial data by year-end
News | Pharmaceuticals
Sequana Medical Announces FDA Clearance of IND Application for DSR 2.0 for Treatment of Congestive Heart Failure

May 2, 2023 — Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and ...

Home May 02, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now